RexMedical- Option* Vena Cava Filter IDE Study

RexMedical- Option* Vena Cava Filter IDE Study

This study is designed to evaluate the safety and efficacy of the RexMedical Option* Vena Cava Filter in the treatment of patients who are at increased risk for Pulmonary Embolism and require caval interruption.

Key Inclusion Criteria:

• Patient is at least 18 years of age
• Patient requires temporary or permanent caval interruption

Key Exclusion Criteria:

• Patient has pre-existing filter implanted in her/her vasculature or has undergone filter retrieval within 60 days prior to study device implant
• Patient is currently enrolled in another investigational device or drug trial